Traverse, NS-LIJ Win Grant to Treat Osteoarthritis

July 29, 2014
Traverse, NS-LIJ Win Grant to Treat Osteoarthritis

Stony Brook-based Traverse Biosciences and the Feinstein Institute for Medical Research have received a $223,979 technology transfer grant to develop a new treatment for osteoarthritis.

The money comes by way of  the National Institute of Health, which is funding Traverse Biosciences and the research offshoot of the North Shore-Long Island Jewish Health System  to evaluate the effectiveness of Traverse’s drug, known as TRB-N0224.

Daniel Grande, director of the institute’s orthopaedic research laboratory, will lead the research for the institute, serving and collaborating with Traverse Biosciences.

Osteoarthritis is a common form of musculoskeletal disease that affects 27 million Americans, according to the Stony Brook company.

Yahoo Finance
July 29,2014
Feinstein Institute Receives $223,979 Small Business Technology Transfer Award In Partnership With Traverse Biosciences

Read this Story

Focus onHealth TV

Watch Focus onHealth, Northwell Health's TV show. It's the healthy way to stay informed!